cysteine has been researched along with erastin in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 5 (71.43) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Li, X; Liu, L; Liu, Y; Xue, Y; Yu, B | 1 |
| Koyanagi, S; Kusunose, N; Matsunaga, N; Ohdo, S; Shiromizu, S; Yamauchi, T | 1 |
| Hua, X; Huang, H; Wang, Z; Xie, X; Yang, X | 1 |
| Capelletti, MM; Manceau, H; Peoc'h, K; Puy, H | 1 |
| Koshiishi, I; Nagai, S; Takigawa, Y; Torii, S; Yoshida, M | 1 |
| Alothaim, T; Charbonneau, M; Tang, X | 1 |
| Allen, AE; Locasale, JW; Reid, MA; Sun, Y; Wei, F | 1 |
1 review(s) available for cysteine and erastin
| Article | Year |
|---|---|
Ferroptosis in Liver Diseases: An Overview.
Topics: alpha-Tocopherol; Animals; Autophagy; Chemical and Drug Induced Liver Injury; Cyclohexylamines; Cysteine; Ferroptosis; Glutathione; Heme; Humans; Iron; Kelch-Like ECH-Associated Protein 1; Lipid Peroxidation; Lipoxygenase; Liver Diseases; Liver Neoplasms; Oxidative Stress; Phenylenediamines; Phospholipid Hydroperoxide Glutathione Peroxidase; Piperazines; Quinoxalines; Reactive Oxygen Species; Reperfusion Injury; Signal Transduction; Sorafenib; Spiro Compounds; Sulfasalazine; Tumor Suppressor Protein p53 | 2020 |
6 other study(ies) available for cysteine and erastin
| Article | Year |
|---|---|
Erastin sensitizes glioblastoma cells to temozolomide by restraining xCT and cystathionine-γ-lyase function.
Topics: Amino Acid Transport System y+; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biological Transport; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Cystathionine gamma-Lyase; Cysteine; Dacarbazine; Drug Resistance, Neoplasm; Enzyme Activation; Glioblastoma; Glutathione; Humans; NF-E2-Related Factor 2; Piperazines; Reactive Oxygen Species; RNA Interference; RNA, Small Interfering; Sulfasalazine; Temozolomide | 2015 |
Dosing Time-Dependent Changes in the Anti-tumor Effect of xCT Inhibitor Erastin in Human Breast Cancer Xenograft Mice.
Topics: A549 Cells; Animals; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cysteine; Dose-Response Relationship, Drug; Glutathione; HeLa Cells; Hep G2 Cells; Heterografts; Humans; MCF-7 Cells; Mice; Piperazines | 2019 |
Real-Time Imaging Redox Status in Biothiols and Ferric Metabolism of Cancer Cells in Ferroptosis Based on Switched Fluorescence Response of Gold Carbon Dots.
Topics: Carbon; Cell Line, Tumor; Cysteine; Ferroptosis; Fluorescent Dyes; Glutathione; Gold; Humans; Iron; Light; Metal Nanoparticles; Microscopy, Confocal; Microscopy, Fluorescence; Neoplasms; Oxidation-Reduction; Piperazines; Quantum Dots | 2020 |
Botanical sulfane sulfur donors inhibit ferroptotic cell death caused by the depletion of cysteine.
Topics: Allyl Compounds; Antioxidants; Brassica; Cell Death; Cell Line, Tumor; Cysteine; Ferroptosis; Garlic; Glutathione; Humans; Hydrogen Sulfide; Lipid Peroxides; Piperazines; Plant Extracts; Sulfides; Sulfur | 2021 |
HDAC6 inhibitors sensitize non-mesenchymal triple-negative breast cancer cells to cysteine deprivation.
Topics: Anilides; Carbamates; Cell Death; Cell Line, Tumor; Cysteine; Enzyme Activation; Epithelial Cells; Female; Gene Knockout Techniques; HEK293 Cells; Histone Deacetylase 6; Histone Deacetylase Inhibitors; Homeostasis; Humans; Hydroxamic Acids; Indoles; Neoplasm Proteins; Oxazoles; Piperazines; Protein Kinase C; Small Molecule Libraries; Transcription, Genetic; Transcriptome; Triple Negative Breast Neoplasms; Zinc | 2021 |
Nucleotide metabolism is linked to cysteine availability.
Topics: Cell Death; Cysteine; Ferroptosis; Glutathione Peroxidase; Lipid Peroxidation; Nucleotides; Piperazines | 2023 |